Avadel Pharmaceuticals (AVDL) Beginning Cash Balance: 2009-2024
Historic Beginning Cash Balance for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to -$20.2 million.
- Avadel Pharmaceuticals' Beginning Cash Balance fell 122.81% to -$13.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$23.3 million, marking a year-over-year decrease of 132.45%. This contributed to the annual value of -$20.2 million for FY2024, which is 147.19% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Beginning Cash Balance stood at -$20.2 million for FY2024, which was down 147.19% from $42.8 million recorded in FY2023.
- In the past 5 years, Avadel Pharmaceuticals' Beginning Cash Balance ranged from a high of $71.7 million in FY2021 and a low of -$23.3 million during FY2022.
- Its 3-year average for Beginning Cash Balance is -$221,000, with a median of -$20.2 million in 2024.
- In the last 5 years, Avadel Pharmaceuticals' Beginning Cash Balance skyrocketed by 633.80% in 2021 and then tumbled by 147.19% in 2024.
- Avadel Pharmaceuticals' Beginning Cash Balance (Yearly) stood at $9.8 million in 2020, then spiked by 633.80% to $71.7 million in 2021, then plummeted by 132.45% to -$23.3 million in 2022, then surged by 283.96% to $42.8 million in 2023, then slumped by 147.19% to -$20.2 million in 2024.